136
Participants
Start Date
October 31, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
March 31, 2015
GKT137831
1 capsule of 100 mg twice a day for the first 6 weeks of treatment, and 2 capsules of 100 mg twice a day for next 6 weeks of treatment
Placebo
1 capsule of Placebo, twice a day, oral treatment self-administered by the patient for the 12 weeks of treatment.
Royal Prince Alfred Hospital, Camperdown
Nemocnice Havlickuv Brod, Huzová
Baker Institute, Melbourne
Austin Health, Heidelberg
Maroondah ECRU, Ringwood East
Deakin University school of medicine, Geelong
IKEM, Prague
ZKS Suedbrandenburg GmbH, Elsterwerda
Captain Stirling Medical Centre, Nedlands
Milan Kvapil s.r.o. diabetology ambulance, Prague
McGuire VA Medical Center, Richmond
KO-MED Centra Kliniczne Sp. z o.o., Staszów
The Center for Diabetes and Endocrine Care, Hollywood
Pines Clinical Research Inc., Pembroke Pines
Clinical Research of South Florida, Coral Gables
Genoma Research Group, Inc., Miami
Coral Research Clinic, Miami
Jacksonville Center for Clinical Research, Jacksonville
Volunteer Medical Research, Port Charlotte
Southeast Renal Research Institute, Chattanooga
Medicus w Opolu sp z o.o., Opole
LLC DBA AccessMD Clinical Research, Dayton
Community Medical Research Partners, Indianapolis
IDFM, München
Zablocki VAMC, Milwaukee
IKFE - Institute for Clinical Research and Development, Mainz
John H. Stroger Jr. Hospital of Cook County, Chicago
Studienzentrum Haematologie/Onkologie/Diabeteologie, Aschaffenburg
Kansas City VA Medical Center, Kansas City
Creighton Diabetes Center, Omaha
The University of Texas Southwestern Medical Center, Dallas
17070 Red Oak dr Ste 103, Houston
Dialysis West University Health System, San Antonio
Advanced Arizona Clinical Research, Tucson
The Endocrine Medical Group, Inc, Orange
Endocrine Research Inc., Vancouver
LMC Diabetes & Endocrinology, Brampton
Clinical Research Solutions, Kitchener
LMC Diabetes and Endocrinology, Thornhill
Toronto East General Medical Centre, Toronto
Medpharmgene, Montreal
Oblastni nemocnice Jicin a.s., Nový Bydžov
Faculty Hospital and Palacky University Olomouc, Olomouc
Centrum Badaa Klinicznych PI-House Sp. z o.o., Gdansk
LANDA Specjalistyczne Gabinety Lekarskie, Krakow
Praktyka Lekarska Ewa Krzyzagorska, Poznan
Department of Nephrology, Transplantationa and Internal Medicine, Szczecin
Medica Pro Familia Sp. z o.o. S.K.A., Warsaw
Lead Sponsor
Calliditas Therapeutics AB
INDUSTRY